Modern medicines, including antifungals used for aspergillosis, can be life-saving. But they can also have powerful side effects. One patient recently described developing nerve damage (neuropathy) while on treatment, but never mentioned it to their doctor, because they didn’t know it could be a side effect. Sadly, by the time it was recognised, the damage was permanent.
This story shows why patients and doctors need to work together in partnership to spot and report side effects early — especially when medicines are new and real-world safety data is still limited.
1. From passive role to partnership
In the past, healthcare was one-way: the doctor gave instructions, the patient followed. Today the NHS encourages shared responsibility:
-
Doctors bring their expertise about the illness and treatments.
-
Patients bring their daily experience of living with the condition.
-
Together they can make safer, better-informed decisions.
This partnership is essential for powerful drugs like antifungals, where side effect monitoring depends on both sides working together.
2. Why side effect statistics can be misleading
Leaflets list side effects as “common” or “rare,” often with percentages. But these figures don’t always reflect real life because:
-
Trials are limited – only a few thousand people take part, often younger and healthier than typical NHS patients.
-
Under-reporting is common – doctors and patients often fail to report side effects, especially mild ones.
-
Bias exists – severe or unusual reactions are reported more often than everyday ones.
👉 Bottom line: leaflets tell us what can happen, not always how often it happens.
3. The Yellow Card system
The UK’s main tool for detecting safety issues is the Yellow Card Scheme, run by the MHRA.
-
Anyone can report: doctors, nurses, pharmacists, patients, or carers.
-
Reports are vital: patterns in these reports may reveal risks not seen in trials.
-
Action is taken: if needed, leaflets are updated, warnings issued, or drugs restricted/withdrawn.
You can report suspected side effects at yellowcard.mhra.gov.uk.
4. Why reporting matters
Poor reporting leads to harm:
-
Delayed warnings – e.g. photosensitivity with voriconazole took years to be recognised.
-
Biased safety data – drugs may seem safer than they are.
-
Preventable harm – patients may suffer permanent injury before action is taken.
For new medicines (marked with a ▼ black triangle in the BNF and leaflets), the MHRA asks for all side effects to be reported, no matter how small.
5. Extra protections for new medicines
When a drug is new, safety systems are stronger than usual:
-
Black triangle (▼) – signals “additional monitoring” so all suspected ADRs should be reported.
-
Specialist prescribing – new antifungals are usually limited to centres like NAC.
-
Closer monitoring – frequent blood tests, drug levels, eye or skin checks depending on risk.
-
Risk Management Plans – agreed with regulators, spelling out what to watch for.
-
Post-marketing studies – Phase 4 trials track safety in real-world patients.
These safeguards are extensive, but not fool-proof. Rare or long-term effects may still emerge only after years of wider use.
6. The NHS challenge
Despite the systems:
-
Only a small percentage of doctors file Yellow Card reports each year.
-
Most GPs never prescribe brand-new drugs — so reporting falls heavily on specialist centres like NAC.
-
Under-reporting risks harm, increases NHS costs, and erodes trust.
7. Who sets the rules?
Several organisations provide guidance on reporting and safety:
-
MHRA (UK regulator): runs Yellow Card, monitors new and established drugs, and issues safety updates.
-
BNF (British National Formulary): highlights side effects, black triangle drugs, and links to reporting tools.
-
GMC (General Medical Council): obliges doctors to report serious ADRs and all reactions to ▼ drugs.
-
EMA (European Medicines Agency): operates EudraVigilance, pooling reports from across Europe.
-
Global standards: the UK follows international rules (ICH E2B) so data is shared worldwide.
8. What patients can do
You are central to this safety net:
-
Be observant – notice anything new or unusual.
-
Keep a record – note when it started, how often, and any changes with medication.
-
Report promptly – tell your team and consider submitting a Yellow Card yourself.
-
Ask questions – “What side effects should I look out for? Which are urgent? How will we monitor this drug?”
-
Use trusted sources – NHS.uk, bnf.nice.org.uk, NAC, or your pharmacist.
9. The reality of side effects
For many, side effects are not “minor inconveniences.” They can mean:
-
Permanent disability (e.g. nerve or vision damage).
-
Loss of independence or mobility.
-
Social isolation and depression.
That’s why side effect monitoring is not just bureaucracy — it’s about protecting real lives.
Key message
The systems around new medicines are extensive but not fool-proof. That’s why patients and doctors must work as partners.
👉 If you notice something new, strange, or worrying while on antifungal medication — however small — tell your healthcare team and consider reporting it. Your report may be the missing piece that protects you and others.
Latest News posts
News archive